Print Page | Contact Us | Report Abuse | Sign In | Register
President's Message
Blog Home All Blogs
The latest update from the President of the American Society of Experimental Neurotherapeutics.

 

Search all posts for:   

 

ASENT takes the next step toward growth

Posted By ASENT President Martha Morrell, MD, Wednesday, December 6, 2017

Dear Friends:

For the past decade, American Society for Experimental NeuroTherapeutics (ASENT) has been managed by the dedicated team at Association Resources. This year, however, marks a transition for ASENT. As of November 17, 2017 we have moved away from Association Resources to become a stand alone nonprofit. We are grateful to Marty Rotblatt and Association Resources for their leadership, and we look forward to a bright future through a strong and engaging meeting with the support of an outstanding journal.

We are thankful to the former ASENT team at Association Resources including Jeff Melin, Cynthia Caron, Karan Murray, and George Ghitsa who not only grew the annual meeting and the membership but increased the presence in the industry at a critical time. A special note of appreciation must also go out to the Association Resources accounting team who will continue to process meeting registration and membership payments through the end of 2017.

As we look forward, many of you know the ASENT Annual Meeting is an opportunity to connect with representatives of academia, industry, advocacy, government and key investment leaders who share a commitment to neurotherapeutic solutions. The annual meeting will take place on March 7-10, 2018 at the Hilton Rockville in Rockville, MD. Registration for the ASENT 20th Annual Meeting is now open. I hope you will take a moment to review the advance program and register.

Of course the work of the organization continues and many of you have already met our new Executive Director, Jessica Keenan Smith. I know she is looking forward to working with each of you to take ASENT to the next level. Also joining the team is Sandy Pizzoferrato. Sandy has a long career in association management and will work with Jessica to ensure ASENT’s operations run as they should. We are also lucky to have the support of Terrie Blalock who, as many of you know, has been a dedicated volunteer for ASENT. Terrie will spend her time supporting ASENT through the process of securing valuable sponsorship dollars.

Thanks so much for all you do for ASENT. We look forward to growing this organization together.

Marty

Martha Morrell, MD
Chief Medical Officer, NeuroPace, Inc.
Clinical Professor of Neurology, Stanford University
President, ASENT

This post has not been tagged.

Share |
PermalinkComments (0)
 

Meet our new Executive Director

Posted By ASENT President Martha Morrell, MD, Wednesday, December 6, 2017

Dear Friends,Martha Morrell, MD

Many of you are not just members, but are also dedicated volunteers of ASENT, and your efforts continue to make an enormous impact on the success of this organization. Of course, all organizations grow and change over time and ASENT is ready to take on one such change. I am pleased to introduce you to our new Executive Director, Jessica Keenan Smith.

Jessica has been involved in the neurology community both as a nonprofit leader and a patient advocate since 2009. She comes to ASENT having served as Director of Education and Membership for four years with the American Neurological Association, and as Founder of Living Well With Epilepsy. Prior to her time in neurology, she led a donor relations team for the Wharton School at the University of Pennsylvania, and created marketing materials for Continuum Health Partners. We look forward to making the most of her extensive skill set as we prepare for ASENT’s 20th Annual Meeting.

I also want to thank Jeff Melin for his continued assistance over the next few months. Jeff has been invaluable in his support as we prepare for our upcoming annual meeting. He will continue to provide institutional memory through the next few months. On behalf of the Board of Directors, I cannot thank Jeff enough for his work and dedication to ASENT.

If you have not attended a meeting recently, I encourage you to plan to attend. Our Pipeline Session is unique to ASENT, where you will hear presentations on the discovery and development of new CNS therapeutics from innovators in industry, academia and government—all on the same stage. Symposium topics include the impact of new technologies on neurotherapeutics, innovative designs in clinical trials, developing treatments for rare neurological diseases, non-small molecule therapies and strategies to spur investments in neurotherapeutics. The scientific sessions will address emerging therapies in a wide range of topics including Epilepsy, Parkinson’s Disease, Alzheimer’s Disease, ALS, Migraine, and more. We are also offering our second day-long course in Translational Research. Finally, we are looking forward to opening the call for abstracts for our poster presentations.

I encourage you to save the date for the upcoming ASENT 20th Annual Meeting from March 7 – 10, 2018, at the Hilton Washington DC/Rockville Hotel and Executive Meeting Center. Registration will open soon. I look forward to seeing you in Washington DC.

Thanks,

Martha Morrell, MD
Chief Medical Officer, NeuroPace, Inc.
Clinical Professor of Neurology, Stanford University
President, ASENT

This post has not been tagged.

Share |
PermalinkComments (0)
 

American Society for Experimental Neurotherapeutics
230 Kings Highway East, Ste 245
Haddonfield, NJ 08033
p: 833.273.6800
e: sandrapizzoferrato.asent@gmail.com

   Connect with Us